Fulla Y - Search Results

1

[The level of evidence for the use of biomarkers in the early detection of prostate cancer].

Lamy PJ, Gauchez AS, Salomon L, Haugh M, Ceraline J, Fulla Y, Georges A, Larré S, Loric S, Luporsi E, Martin PM, Mazerolles C, Molinié V, Mongiat-Artus P, Piffret J, Thuillier F, Perrin P, Rebillard X; Groupe de biologie de la prostate. Lamy PJ, et al. Among authors: fulla y. Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):227-32. doi: 10.1684/abc.2016.1128. Ann Biol Clin (Paris). 2016. PMID: 27029727 Free article. Review. French.

2

[PSA kinetics after total prostatectomy].

Riedinger JM, Eche N, Fulla Y, Thuillier F. Riedinger JM, et al. Among authors: fulla y. Ann Biol Clin (Paris). 2009 Jan-Feb;67(1):39-46. doi: 10.1684/abc.2009.0298. Ann Biol Clin (Paris). 2009. PMID: 19189884 Free article. Review. French.

3

[PSA kinetics after radiotherapy].

Riedinger JM, Eche N, Bachaud JM, Crehange G, Fulla Y, Thuillier F. Riedinger JM, et al. Among authors: fulla y. Ann Biol Clin (Paris). 2009 Jul-Aug;67(4):395-404. doi: 10.1684/abc.2009.0339. Ann Biol Clin (Paris). 2009. PMID: 19656762 Free article. Review. French.

4

Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.

Peyromaure M, Badoual C, Camparo P, Grabar S, Goulvestre C, Fulla Y, Vieillefond A, Mao K, Dinh-Xuan AT. Peyromaure M, et al. Among authors: fulla y. Oncol Rep. 2007 Jul;18(1):145-9. Oncol Rep. 2007. PMID: 17549360

5

Pro PSA : a "pro cancer" form of PSA?

Peyromaure M, Fulla Y, Debré B, Dinh-Xuan AT. Peyromaure M, et al. Among authors: fulla y. Med Hypotheses. 2005;64(1):92-5. doi: 10.1016/j.mehy.2004.06.006. Med Hypotheses. 2005. PMID: 15533620

6

Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer.

Peyromaure M, Goulvestre C, Fulla Y, Grabar S, Debré B, Dinh-Xuan AT. Peyromaure M, et al. Among authors: fulla y. Urology. 2005 Sep;66(3):687-91. doi: 10.1016/j.urology.2005.03.082. Urology. 2005. PMID: 16140116

7

[Role of selective venous catheterization with assay of parathormone 1-84 in the treatment of persistent hyperparathyroidism].

Abboud B, Pitre J, Bonnichon P, Legmann P, Fulla Y, Richard B, Chapuis Y. Abboud B, et al. Among authors: fulla y. Ann Chir. 1997;51(2):130-5. Ann Chir. 1997. PMID: 9297868 French.

8

Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients.

Pichon MF, Brun GL, Hacene K, Basuyau JP, Riedinger JM, Eche N, Fulla Y, Charlier-Bret N. Pichon MF, et al. Among authors: fulla y. Clin Chem Lab Med. 2009;47(8):985-92. doi: 10.1515/CCLM.2009.213. Clin Chem Lab Med. 2009. PMID: 19548847

9

[Ultra-sensitive TSH and the TRH test in the follow-up of thyroid and pituitary diseases].

Mathe C, Spitzmuller M, Fulla Y, Ingrand J, Luton JP. Mathe C, et al. Among authors: fulla y. Ann Endocrinol (Paris). 1989;50(1):73-6. Ann Endocrinol (Paris). 1989. PMID: 2499242 French.

10

[Surgery of primary hyperparathyroidism by unilateral approach under local anesthesia and intraoperative determination of PTH 1-84].

Chapuis Y, Richard B, Fulla Y, Bonnichon P, Tarla E, Icard P. Chapuis Y, et al. Among authors: fulla y. Ann Endocrinol (Paris). 1994;55(5):171-4. Ann Endocrinol (Paris). 1994. PMID: 7857082 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters